Literature DB >> 28490575

EZH2 Regulates the Developmental Timing of Effectors of the Pre-Antigen Receptor Checkpoints.

Jennifer A Jacobsen1, Jennifer Woodard1, Malay Mandal2, Marcus R Clark1,2, Elizabeth T Bartom3, Mikael Sigvardsson4, Barbara L Kee5,6.   

Abstract

The histone methyltransferase EZH2 is required for B and T cell development; however, the molecular mechanisms underlying this requirement remain elusive. In a murine model of lymphoid-specific EZH2 deficiency we found that EZH2 was required for proper development of adaptive, but not innate, lymphoid cells. In adaptive lymphoid cells EZH2 prevented the premature expression of Cdkn2a and the consequent stabilization of p53, an effector of the pre-Ag receptor checkpoints. Deletion of Cdkn2a in EZH2-deficient lymphocytes prevented p53 stabilization, extended lymphocyte survival, and restored differentiation resulting in the generation of mature B and T lymphocytes. Our results uncover a crucial role for EZH2 in adaptive lymphocytes to control the developmental timing of effectors of the pre-Ag receptor checkpoints.
Copyright © 2017 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28490575      PMCID: PMC5527689          DOI: 10.4049/jimmunol.1700319

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  53 in total

Review 1.  Transcriptional regulation of innate and adaptive lymphocyte lineages.

Authors:  Maria Elena De Obaldia; Avinash Bhandoola
Journal:  Annu Rev Immunol       Date:  2015-02-04       Impact factor: 28.527

2.  Ezh1 is required for hematopoietic stem cell maintenance and prevents senescence-like cell cycle arrest.

Authors:  Isabel Hidalgo; Antonio Herrera-Merchan; Jose Manuel Ligos; Laura Carramolino; Javier Nuñez; Fernando Martinez; Orlando Dominguez; Miguel Torres; Susana Gonzalez
Journal:  Cell Stem Cell       Date:  2012-11-02       Impact factor: 24.633

Review 3.  BACH2-BCL6 balance regulates selection at the pre-B cell receptor checkpoint.

Authors:  Srividya Swaminathan; Cihangir Duy; Markus Müschen
Journal:  Trends Immunol       Date:  2013-12-10       Impact factor: 16.687

4.  Id3 inhibits B lymphocyte progenitor growth and survival in response to TGF-beta.

Authors:  B L Kee; R R Rivera; C Murre
Journal:  Nat Immunol       Date:  2001-03       Impact factor: 25.606

5.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

Review 6.  Mechanisms of pre-B-cell receptor checkpoint control and its oncogenic subversion in acute lymphoblastic leukemia.

Authors:  Maike Buchner; Srividya Swaminathan; Zhengshan Chen; Markus Müschen
Journal:  Immunol Rev       Date:  2015-01       Impact factor: 12.988

7.  A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate.

Authors:  Yin C Lin; Suchit Jhunjhunwala; Christopher Benner; Sven Heinz; Eva Welinder; Robert Mansson; Mikael Sigvardsson; James Hagman; Celso A Espinoza; Janusz Dutkowski; Trey Ideker; Christopher K Glass; Cornelis Murre
Journal:  Nat Immunol       Date:  2010-06-13       Impact factor: 25.606

8.  Yin Yang 1 Promotes Thymocyte Survival by Downregulating p53.

Authors:  Liang Chen; Daniel P Foreman; Derek B Sant'Angelo; Michael S Krangel
Journal:  J Immunol       Date:  2016-02-03       Impact factor: 5.422

9.  Yin Yang 1 is a critical regulator of B-cell development.

Authors:  Huifei Liu; Marc Schmidt-Supprian; Yujiang Shi; Elias Hobeika; Natasha Barteneva; Hassan Jumaa; Roberta Pelanda; Michael Reth; Jane Skok; Klaus Rajewsky; Yang Shi
Journal:  Genes Dev       Date:  2007-05-15       Impact factor: 11.361

10.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

View more
  11 in total

1.  Cutting Edge: Lymphomyeloid-Primed Progenitor Cell Fates Are Controlled by the Transcription Factor Tal1.

Authors:  Renée F de Pooter; Sheila Dias; Munmun Chowdhury; Elisabeth T Bartom; Michael K Okoreeh; Mikael Sigvardsson; Barbara L Kee
Journal:  J Immunol       Date:  2019-04-08       Impact factor: 5.422

2.  EZH2 Represses the B Cell Transcriptional Program and Regulates Antibody-Secreting Cell Metabolism and Antibody Production.

Authors:  Muyao Guo; Madeline J Price; Dillon G Patterson; Benjamin G Barwick; Robert R Haines; Anna K Kania; John E Bradley; Troy D Randall; Jeremy M Boss; Christopher D Scharer
Journal:  J Immunol       Date:  2017-12-29       Impact factor: 5.422

3.  Polycomb repressive complex 2 is a critical mediator of allergic inflammation.

Authors:  Christine R Keenan; Nadia Iannarella; Alexandra L Garnham; Alexandra C Brown; Richard Y Kim; Jay C Horvat; Philip M Hansbro; Stephen L Nutt; Rhys S Allan
Journal:  JCI Insight       Date:  2019-05-16

Review 4.  Roadmap to a plasma cell: Epigenetic and transcriptional cues that guide B cell differentiation.

Authors:  Keenan J Wiggins; Christopher D Scharer
Journal:  Immunol Rev       Date:  2020-12-05       Impact factor: 12.988

5.  Integrated Analysis of RNA-Binding Proteins Associated With the Prognosis and Immunosuppression in Squamous Cell Carcinoma of Head and Neck.

Authors:  Guangsheng Hu; Qingshan Jiang; Lijun Liu; Hong Peng; Yaya Wang; Shuyan Li; Yanhua Tang; Jing Yu; Jing Yang; Zhifeng Liu
Journal:  Front Genet       Date:  2021-01-11       Impact factor: 4.599

Review 6.  Easy or Not-The Advances of EZH2 in Regulating T Cell Development, Differentiation, and Activation in Antitumor Immunity.

Authors:  Jiaqi Huang; Jie Zhang; Zhengyang Guo; Chen Li; Zhen Tan; Junjie Wang; Jianling Yang; Lixiang Xue
Journal:  Front Immunol       Date:  2021-10-19       Impact factor: 7.561

7.  Oncogenic and Tumor Suppressor Functions for Lymphoid Enhancer Factor 1 in E2a-/- T Acute Lymphoblastic Leukemia.

Authors:  Tiffany Carr; Stephanie McGregor; Sheila Dias; Mihalis Verykokakis; Michelle M Le Beau; Hai-Hui Xue; Mikael Sigvardsson; Elizabeth T Bartom; Barbara L Kee
Journal:  Front Immunol       Date:  2022-03-18       Impact factor: 7.561

8.  Link between the EZH2 noncanonical pathway and microtubule organization center polarization during early T lymphopoiesis.

Authors:  Frederique Deshayes; Magali Fradet; Sandra Kaminski; Mireille Viguier; Jean-Pol Frippiat; Stephanie Ghislin
Journal:  Sci Rep       Date:  2022-03-07       Impact factor: 4.379

Review 9.  Cuproptosis and cuproptosis-related genes in rheumatoid arthritis: Implication, prospects, and perspectives.

Authors:  Jianan Zhao; Shicheng Guo; Steven J Schrodi; Dongyi He
Journal:  Front Immunol       Date:  2022-08-04       Impact factor: 8.786

10.  BRWD1 orchestrates epigenetic landscape of late B lymphopoiesis.

Authors:  Malay Mandal; Mark Maienschein-Cline; Patrick Maffucci; Margaret Veselits; Domenick E Kennedy; Kaitlin C McLean; Michael K Okoreeh; Sophiya Karki; Charlotte Cunningham-Rundles; Marcus R Clark
Journal:  Nat Commun       Date:  2018-09-24       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.